A summary is not diligence.
Evidence attached to the conclusions is.
The most important question is not what the IC knows.
It's what the analysts did not think to check.
Material is captured as claims to be tested, not conclusions to accept.
Agents test every claim across market, product, technical, traction, team, and risk.
Economics and assumptions are modelled under bear, base, and bull conditions.
Conviction score, evidence ledger, open risks, and decision-changing questions.
Sizes the addressable market from primary sources. Tests TAM claims. Maps adjacent demand pools.
A summary is not diligence.
Evidence attached to the conclusions is.
Monitor — organic demand is unproven. Revisit after two quarters of post-cut utilization data; the key threshold is 55% utilization sustained without the subsidy.
RESEARCH SCOPEApex is a non-custodial lending market: depositors supply assets to earn yield; borrowers post collateral and pay interest on what they borrow. Total value locked reached $1.2B at the data cutoff[01], up 240% over twelve months[02]. The growth is almost entirely supply-side: utilization (the share of deposits actively borrowed) sits at 34%[03], against the 60–75% range typical of mature lending markets such as Aave V3 and Compound V3. Apex funds the 7.3-point spread between 2.1% base yield and 9.4% total depositor yield by distributing APX tokens at 4.2M per month[05] (approximately $19M per year in native token dilution at spot price). Data cutoff: 2026-05-18.
An estimated 64% of deposits are there for the token rewards, not the lending product: deposits above the point where borrower interest alone would retain them[06]. Comparable episodes (Compound's COMP farming epoch, November 2021, and Anchor Protocol's 20% yield era) produced 55–80% TVL loss within two quarters of similar reward cuts[07]. In Q3 2026, monthly APX emissions fall from 4.2M to 1.9M tokens, a 54% cut[08]. At current utilization, deposit yield falls to approximately 3.7% after the cut[09] — below every major lending comparable and below the risk-free rate, the threshold at which incentive-seeking capital has no reason to stay.
Sustained utilization above 55% for two consecutive quarters after the cut would signal genuine borrower demand capable of sustaining competitive yields without the subsidy[10]. APX token price is a secondary variable: the yield calculation assumes the current APX price; a 40% APX decline pushes effective total yield below the base rate even before the cut takes effect[11]. The borrow side is also concentrated: 71% of interest revenue comes from a single collateral asset[10], so the recovery depends on one asset holding up.
We do not yet know whether borrowers are net beneficiaries of the same APX emissions they help fund[11]. If borrowers offset their 7.2% gross borrowing cost with APX rewards, removing the subsidy may compress both sides of the balance sheet simultaneously — a utilization collapse, not a partial deposit exit. Apex's Q3 documentation contains no published utilization targets, leaving the key variable unquantified.
Checks claims against evidence.
Surfaces contradictions.
Shows which assumptions drive the case.
Stress-tests the logic behind the case.